Safety/Tolerability and Pharmacokinetic Study of SID142
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
A randomized, open-label, oral multiple dosing, two-part, two-way crossover clinical trial to
evaluate the safety/tolerability and pharmacokinetic profiles of SID142 in healthy volunteers